Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: US BIOSERVICES CORPORATION
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2021-07-26 to 2022-04-01
Current total value of award: $14413.68
Description: REVLIMID 4MG